SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-043213
Filing Date
2010-05-04
Accepted
2010-05-04 09:39:12
Documents
8
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q b80544e10vq.htm 10-Q 258627
2 EX-10.1 b80544exv10w1.htm EX-10.1 17704
3 EX-10.2 b80544exv10w2.htm EX-10.2 69583
4 EX-31.1 b80544exv31w1.htm EX-31.1 8084
5 EX-31.2 b80544exv31w2.htm EX-31.2 8368
6 EX-32.1 b80544exv32w1.htm EX-32.1 4333
7 EX-32.2 b80544exv32w2.htm EX-32.2 4107
8 GRAPHIC b80544b8054401.gif GRAPHIC 11052
  Complete submission text file 0000950123-10-043213.txt   387724
Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
CORNERSTONE THERAPEUTICS INC (Filer) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50767 | Film No.: 10795204
SIC: 2834 Pharmaceutical Preparations